Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatment With Cenegermin in Moderate to Severe Dry Eye-Associated Neurotrophic Keratitis

NCT06947850 is registered in ClinicalTrials.gov with Toyos Clinic as lead sponsor.

NCT NCT06947850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06947850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatment With Cenegermin in Moderate to Severe Dry Eye-Associated Neurotrophic Keratitis
Lead sponsor
Toyos Clinic
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 21, 2023
Completion date
September 25, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, neurotrophic keratitis